Key Takeaways Randomized controlled trial results published in the International Journal of Tissue Repair demonstrate BioRetain® allografts significantly improve probability of achieving lasting wound closure
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., October 30, 2025 – PRISM MediaWire (Press Release Service – Press
Live Technical Demonstration Validates NeuroSense AI Platform Feasibility; Development Moves Forward with Proven Core Technologies Halberd Demonstrates NeuroSense AI FeasibilityHalberd Corporation successfully validated its NeuroSense
Protext Mobility to launch IR Presentation & MicrositeTXTM is rolling out a modern investor hub to elevate transparency and engagement, aligning communications with top-tier governance
NEW YORK, Oct. 17, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Protext Mobility, Inc. (OTC: TXTM), an emerging leader in
Planned uplist to OTCQB Venture Exchange, if approved will follow completion of audit and previously announced reverse split Mankato, Minn., October 9, 2025 – PRISM
WILMINGTON, DE, October 8, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Protext Mobility, Inc. (OTC: TXTM), an emerging innovator in
New 19-Series solution targets wide range of chemical contaminants SOUTH ORANGE, NJ, October 8, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution)
Company recognized for breakthrough Nociscan solution for chronic low back pain, one of the most widespread health challenges BROOMFIELD, Colo., October 7, 2025 – PRISM
Leading Industrial Biotechnology Company Delivers Key Equipment For Aemetis Project CUPERTINO, Calif., October 7, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution)
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
